DeSantis Damon
- SEC CIK
- 0001889279
Latest role at each company
- CELH Celsius Holdings, Inc.Directoras of Sep 15, 2026
- INBP INTEGRATED BIOPHARMA INCDirector, 10% Owneras of Jun 25, 2026
Trades
Every Form 4 that lists DeSantis Damon as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| CELHCelsius Holdings, Inc. | Sep 15, 20264:17 PM ET | Sep 14 – Sep 15, 2026 | DeSantis DamonDirector | PPurchaseCommon Stock, $0.001 par value per share | +36K | $27.7833 | +$1M | 2.73M | +1.3% | SEC |